By Laurence Norman 

BRUSSELS--The two Belgian financial firms that failed the European Central Bank and European Banking Authority stress tests said they had no need to raise further capital as a result of the outcome.

Belgium's AXA Bank Europe said Sunday it had carried out a 225-million-euro ($285 million) capital injection last month which addressed its capital shortfall.

The bank failed the adverse-scenario ECB stress test, with the ECB saying it would have a 3.4% Common Equity Tier 1 capital ratio in the adverse scenario in 2016, well below the 5.5% required.

However the bank said that last month its parent company injected 135 million euros in common equity Tier 1 capital and a 90-million-euro intragroup Contingent Convertible bond, which addressed its capital needs.

"AXA Group (CS.FR, AXAHY) has anticipated the outcome of the adverse macro scenario of the ECB stress test by providing the necessary capital resources for AXA Bank Europe to comply with the ECB" requirements, the bank said in a press release.

The bank said that "no additional measures to strengthen the solvency position" of AXA Bank Europe are required.

The bank said that following the capital injection it has overall Tier 1 capital of 992 million euros and a forecast Tier 1 capital ratio of 20.8% as of Sept. 30.

The bank said two legacy portfolios had a significant impact on the stress test result--a structured-bonds portfolio which the bank has been running down since 2008 and was completely sold last month; and a mortgage-credit portfolio in Hungary which the bank has been running down since 2011.

Dexia SA (DEXB), the other Belgian bank that failed the adverse scenario of the stress test, said that no remedial action or state aid was required by the ECB and the EBA after the test. Dexia is being wound down under a resolution plan approved by European Union authorities in 2012.

The bank said it had already boosted its 195-million-euro common equity Tier 1 capital by asset sales in the first three quarters of this year. It also said the adverse scenario test didn't take into account the benefits of a measure granted on the valuation of its sovereign securities holdings.

The ECB and the EBA confirmed Sunday that taking into account the orderly resolution plan of Dexia, which benefits from a government guarantee, there is no need for the bank to raise further capital.

   Write to Laurence Norman at Laurence.Norman@wsj.com 
Axa (EU:CS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Axa Charts.
Axa (EU:CS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Axa Charts.